Kathryn Gunther

Kathryn Gunther

Auto-generated profile, based on publicly available information

Kathryn Gunther

University of Texas Health Science Center at Houston

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MFMarta Frigeni
Marta Frigeni
DRDavid F. Rodriguez‐Buritica
David F. Rodriguez‐Buritica
HSHeather Saavedra
Heather Saavedra
KGKathryn A. Gunther
Kathryn A. Gunther
PHPaul R. Hillman
Paul R. Hillman
HNHope Northrup
Hope Northrup

14 February 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AKAbigail Kacpura
Abigail Kacpura
MFMarta Frigeni
Marta Frigeni
KGKathryn Gunther
Kathryn Gunther
LFLaura Farach
Laura Farach

1 March 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
KGKathryn Gunther
Kathryn Gunther
KMKate Mowrey
Kate Mowrey
LFLaura Schoch Farach
Laura Schoch Farach
Two new cases of 16q22.3q23.3 Duplication syndrome demonstrate that phenotype can vary from severely affected to mild psychiatric concerns, even within the same family and identical duplications.

8 February 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
KGKathryn Gunther
Kathryn Gunther
EIEssam M. Imseis
Essam M. Imseis
JSJoyce P. Samuel
Joyce P. Samuel
EHElizabeth A. Hillman
Elizabeth A. Hillman
TOTiina H. Ojala
Tiina H. Ojala
PHPaul R. Hillman
Paul R. Hillman
Background: Renal‐hepatic‐pancreatic dysplasia type 2 (RHPD2) is a rare condition that has been described in the literature disproportionately in perinatal losses. The main features of liver and kidney involvement are well described, with cardiac malformations and cardiomyopathy adding additional variation to the phenotype. Many patients reported are within larger cohorts of congenital anomalies of kidney and urinary tract (CAKUT) or liver failure, and with minimal phenotypic and clinical course data.Methods: An independent series of phenotypes and prognosis was aggregated from the literature. In this literature review, we describe an additional patient with RHPD2, provide a clinical update on the oldest known living patient, and report the cumulative phenotypes from the existing published patients.Results: With now examining the 17 known patients in the literature, 13 died within the perinatal period‐pregnancy to one year of life. Of the four cases living past the first year of life, one case died at 5 years secondary to renal failure, the other at 30 months secondary to liver and kidney failure. Two are currently alive and well at one year and 13 years. Two cases have had transplantation with one resulting in long‐term survival.Conclusions: These patients serve to expand the existing phenotype of RHPD2 as a perinatal lethal condition into a pediatric disorder with variable expressivity. Additionally, we introduce the consideration of transplantation and outcomes within this cohort and future patients.

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
AKAbigail Kacpura
Abigail Kacpura
KGKathryn Gunther
Kathryn Gunther
MFMarta Frigeni
Marta Frigeni
LFLaura Farach
Laura Farach

15 July 2025
Verified
Preprint
Open access
GRGrace Ra
Grace Ra
JBJessica Bolen
Jessica Bolen
ADAllison Davidson
Allison Davidson
DRDavid Rodriguez-Buritica
David Rodriguez-Buritica
LELaith Enani
Laith Enani
KGKathryn Gunther
Kathryn Gunther